63MO TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV)+ malignancies
Titel:
63MO TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV)+ malignancies
Auteur:
Le Tourneau, C. Cassier, P. Rolland, F. Salas, S. Limacher, J-M. Capitain, O. Lantz, O. Lalanne, A. Ekwegbara, C. Tavernaro, A. Makhloufi, H. Bendjama, K. Delord, J-P.